John Wiley and Sons Class B shares show strong near-term price momentum with volume surging 2.7 times average, but the stock is near its 52-week high with no remaining upside to resistance and heavy research segment concentration, making the risk-reward unfavorable for new buyers.
Thesis pillars
- Strong Momentum Volume Surge↑Improving
- Upside Exhaustion Near High↓Deteriorating
- Research Segment Concentration↓Deteriorating
- +1 more pillar — see the Why tab for full reasoning
John Wiley & Sons, Inc. (WLYB) Stock Analysis
Range Bound setup
Communication Services · Publishing
Hold if already holding. Not a fresh buy at $51.76, but acceptable to hold if already in. Reason: Concentration risk — Product: Research segment (64.0%).
Wiley publishes over 1,800 peer-reviewed academic journals and academic, professional, and education books through its Research and Learning segments, based primarily in the US and UK. In fiscal 2025, 83% of Adjusted Revenue came from digital products, with Research generating... Read more
Hold if already holding. Not a fresh buy at $51.76, but acceptable to hold if already in. Reason: Concentration risk — Product: Research segment (64.0%). Chart setup: RSI 47 mid-range, Bollinger mid-band. Maintain position. Not compelling to add more. Score 6.3/10, moderate confidence.
Passes 6/9 gates (positive momentum, clean insider activity, news events none recent, earnings proximity no date, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.
About John Wiley & Sons, Inc.
About John Wiley & Sons, Inc.
John Wiley & Sons publishes over 1,800 scientific, technical, medical, and scholarly journals through its Research segment, which generated approximately 64% of consolidated revenue in fiscal year 2025 against 35% from the Learning segment. The company's Atypon platform hosts more than 11 million articles from over two thousand publishers and societies. Approximately 49% of consolidated revenue came from outside the United States, with publishing centers spanning the US, UK, Sri Lanka, Germany, and India.
Wiley earns revenue chiefly from Journal Subscriptions and Transformational Agreements, multi-year contracts under which library consortia pay for combined read access and open-access publishing rights, supplemented by per-article Open Access publishing charges and licensing of content, including licensing for training artificial intelligence models. Approximately 46% of Journal Subscriptions revenue derives from publication rights owned by professional societies such as the American Cancer Society and American Heart Association, alliances often lasting decades in exchange for royalty payments. The Learning segment sells print and digital textbooks, WileyPLUS digital courseware, and assessment tools such as Everything DiSC and PXT Select through bookstores, online retailers, and corporate distributor networks, and outsources US book distribution to Cengage Learning.
Show full overview
Wiley has actively pruned its portfolio, divesting non-core education businesses including University Services (sold January 2024), Wiley Edge (sold May 2024, with India operations following in August), and CrossKnowledge (sold August 2024); the resulting Held for Sale or Sold category still represented about 1% of consolidated revenue in fiscal 2025 at a negative 20.6% Adjusted EBITDA margin. The 10-K flags that Sellers Notes and earnout provisions tied to these completed deals remain a source of collection risk if the buyers face financial difficulty, a lingering liability distinct from Wiley's core Research and Learning economics.
See also: Communication Services · Publishing
From John Wiley & Sons, Inc.'s most recent 10-K filing, extracted August 9, 2026.
Recent developments
updated 2026-08-15Recent Developments — John Wiley & Sons, Inc.
Latest news
- NEWS John Wiley & Sons Q4 2026 Earnings Call Transcript — benzinga Jun 17, 2026 neutral
- NEWS John Wiley & Sons Sees FY2027 Adj EPS $4.60-$5.05 vs $4.75 Est — benzinga Jun 16, 2026 neutral
- NEWS John Wiley & Sons Q4 Adj. EPS $1.67 Beats $1.65 Estimate, Sales $447.941M Miss $450.000M Estimate. — benzinga Jun 16, 2026 neutral
- NEWS Earnings Scheduled For June 16, 2026 — benzinga Jun 16, 2026 neutral
Generated 2026-08-15T10:44:22Z.
Thesis
Key Metrics
Quality Signals
Concentration Risks(10-K Item 1A)
- HIGHProductResearch segment64%10-K Item 1: 'Research revenue accounted for approximately 64% of our consolidated revenue in the year ended April 30, 2025'
- MEDIUMProductLearning segment35%10-K Item 1: 'Learning accounted for approximately 35% of our consolidated revenue in the year ended April 30, 2025'
- MEDIUMGeographicrevenue from outside the US49%10-K Item 1: 'approximately 49% of our consolidated revenue was from outside the US'
- MEDIUMSupplierprofessional society-owned journals46%10-K Item 1: 'Approximately 46% of Journal Subscriptions revenue is derived from publication rights that are owned by professional societies and other publishing partners'
Material Events(8-K, last 90d)
- 2026-05-06Item 5.02MEDIUMEVP/GM Research and Learning Jay Flynn departed without cause; Jessica Kowalski (formerly Microsoft, AWS, RELX) appointed EVP/GM Research effective May 11, 2026. No successor named specifically for Learning.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 ceiling hit
Price Targets
Position Sizing
Analyst Consensus
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $51.76, but acceptable to hold if already in. Reason: Concentration risk — Product: Research segment (64.0%). Chart setup: RSI 47 mid-range, Bollinger mid-band. Maintain position. Not compelling to add more. Target $54.40 (+5.1%), stop $49.99 (−3.5%), A.R:R 0.0:1. Score 6.3/10, moderate confidence.
Take-profit target: $54.40 (+5.8% upside). Target $54.40 (+5.1%), stop $49.99 (−3.5%), A.R:R 0.0:1. Stop-loss: $49.99.
Concentration risk — Product: Research segment (64.0%).
John Wiley & Sons, Inc. trades at a P/E of 12.4 (forward N/A). TrendMatrix value score: 9.2/10. Verdict: Hold.
5 analysts cover WLYB with a consensus score of 4.0/5.
What does John Wiley & Sons, Inc. do?Wiley publishes over 1,800 peer-reviewed academic journals and academic, professional, and education books through its...
Wiley publishes over 1,800 peer-reviewed academic journals and academic, professional, and education books through its Research and Learning segments, based primarily in the US and UK. In fiscal 2025, 83% of Adjusted Revenue came from digital products, with Research generating approximately 64% of consolidated revenue and Learning about 35%. Nearly half of Journal Subscriptions revenue stems from decades-long alliances with professional societies.